HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hajime Saito Selected Research

TE 5

7/2015REG Iα activates c-Jun through MAPK pathways to enhance the radiosensitivity of squamous esophageal cancer cells.
1/2011IGFBP3 and BAG1 enhance radiation-induced apoptosis in squamous esophageal cancer cells.
1/2010Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells.
12/2008REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hajime Saito Research Topics

Disease

48Neoplasms (Cancer)
01/2022 - 08/2003
23Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2003
17Esophageal Neoplasms (Esophageal Cancer)
10/2017 - 04/2007
13Neoplasm Metastasis (Metastasis)
01/2022 - 01/2004
11Lung Neoplasms (Lung Cancer)
02/2021 - 08/2008
11Esophageal Squamous Cell Carcinoma
01/2020 - 12/2008
7Lymphatic Metastasis
12/2020 - 09/2005
6Adenocarcinoma
10/2012 - 06/2010
5Infections
01/2016 - 05/2004
4Adenocarcinoma of Lung
01/2022 - 10/2012
4Inflammation (Inflammations)
09/2015 - 10/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2014 - 01/2011
3Carcinoma (Carcinomatosis)
01/2022 - 11/2008
3Buruli Ulcer
05/2015 - 05/2004
3Hyperthermia
08/2014 - 04/2008
3Melanoma (Melanoma, Malignant)
08/2014 - 04/2008
2Fistula
12/2020 - 11/2011
2Pneumonia (Pneumonitis)
04/2019 - 01/2016
2Breast Neoplasms (Breast Cancer)
01/2019 - 06/2014
2Squamous Cell Neoplasms (Squamous Cell Cancer)
07/2012 - 07/2011
2Tuberculosis (Tuberculoses)
06/2011 - 05/2010
2Ulcer
03/2006 - 05/2004
1Intestinal Obstruction (Obstruction, Intestinal)
03/2022
1Turcot syndrome
01/2021
1Pneumothorax
06/2017
1Chylothorax
01/2016
1Aspiration Pneumonia
01/2016
1Renal Insufficiency (Renal Failure)
01/2016
1Periodontitis
01/2016
1Thymoma (Thymic Carcinoma)
01/2016
1Surgical Wound Infection
01/2016

Drug/Important Bio-Agent (IBA)

13Messenger RNA (mRNA)IBA
11/2017 - 01/2004
7C-Reactive ProteinIBA
09/2015 - 10/2009
5Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
4Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2015
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2010
4Carboplatin (JM8)FDA LinkGeneric
07/2020 - 08/2008
4ferumoxides (Feridex)FDA Link
08/2015 - 08/2003
4TE 5IBA
07/2015 - 12/2008
3Keratins (Keratin)IBA
01/2017 - 09/2005
3CytokinesIBA
07/2011 - 11/2009
2Trace Elements (Biometals)IBA
02/2021 - 11/2019
2Fibrin Tissue Adhesive (Fibrin Sealant)IBA
12/2020 - 11/2011
2Cisplatin (Platino)FDA LinkGeneric
07/2020 - 01/2016
2Paclitaxel (Taxol)FDA LinkGeneric
08/2019 - 10/2012
2Bevacizumab (Avastin)FDA Link
08/2019 - 10/2012
2Phosphates (Orthophosphate)IBA
11/2017 - 09/2015
2Ferrosoferric Oxide (Magnetite)FDA Link
08/2015 - 08/2003
2N-formylmethionylphenylalanine (FMP)IBA
08/2014 - 03/2009
22-(4-fluorophenyl)-N-methylsuccinimideIBA
08/2014 - 04/2008
2Transforming Growth Factors (Transforming Growth Factor)IBA
05/2013 - 01/2012
2Histone Deacetylases (Histone Deacetylase)IBA
11/2011 - 10/2010
2Interleukin-10 (Interleukin 10)IBA
07/2011 - 10/2009
2Interleukin-4 (Interleukin 4)IBA
07/2011 - 10/2009
2Interleukin-2 (IL2)IBA
07/2011 - 10/2009
2Chemokine ReceptorsIBA
02/2011 - 06/2010
216S Ribosomal RNAIBA
05/2010 - 11/2007
2Interleukin-6 (Interleukin 6)IBA
01/2010 - 10/2009
2Interferon-gamma (Interferon, gamma)IBA
11/2009 - 10/2009
2AcidsIBA
03/2006 - 05/2004
15'-palmitoyl cytarabine (PLAC)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2021
1Mucin-4IBA
01/2021
1NucleotidesIBA
01/2021
1Prostaglandins AIBA
12/2020
1Carbon MonoxideIBA
12/2020
1Vinorelbine (Navelbine)FDA LinkGeneric
07/2020
1ErbB Receptors (EGF Receptor)IBA
11/2019
1Hemostatics (Antihemorrhagics)IBA
07/2019
1Anti-Bacterial Agents (Antibiotics)IBA
04/2019
1human ERBB2 proteinIBA
01/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2018
1Anaplastic Lymphoma KinaseIBA
11/2017
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
11/2017
1SphingosineIBA
11/2017
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
11/2017
1sphingosine kinaseIBA
11/2017
1LigandsIBA
01/2017
1Biological ProductsIBA
01/2017
1Macrophage Migration-Inhibitory FactorsIBA
01/2017
1MicroRNAs (MicroRNA)IBA
01/2017
1N-acetyltalosaminuronic acid (NAT)IBA
12/2016
1Ethiodized Oil (Ethiodol)FDA Link
01/2016

Therapy/Procedure

15Esophagectomy
01/2020 - 03/2009
8Radiotherapy
01/2016 - 08/2008
7Drug Therapy (Chemotherapy)
03/2022 - 08/2008
7Therapeutics
07/2020 - 07/2008
6Lymph Node Excision (Lymph Node Dissection)
10/2017 - 06/2007
4Neoadjuvant Therapy
10/2017 - 01/2016
3Operative Surgical Procedures
01/2022 - 12/2020
3Segmental Mastectomy (Lumpectomy)
12/2020 - 08/2014
3Adjuvant Chemotherapy
07/2020 - 09/2013
3Chemoradiotherapy
01/2017 - 01/2015
3Thoracotomy
02/2015 - 06/2010
2Induction Chemotherapy
08/2019 - 10/2012
2Thymectomy
01/2016 - 12/2008
2Cardiopulmonary Resuscitation (CPR)
11/2013 - 01/2010
1Immunotherapy
01/2021
1Sutures (Suture)
06/2017
1Renal Dialysis (Hemodialysis)
01/2016